TAM
VNDA icon

THB Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

THB Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-207,900
Closed -$3.38M – 244
2014
Q1 		$3.38M Buy
+207,900
New +$2.96M 0.2% 169

Other funds holding VNDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SCA
Signpost Capital Advisors New York $34.2M AUM 5.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

THB Asset Management's VNDA Position: Q2 2014 in Review

THB Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2014, closing a stake of 207,900 shares — an estimated $3.38M sold.

THB Asset Management first reported a position in VNDA in Q1 2014 and held it in 1 quarter. The position peaked at $3.38M in Q1 2014. 110 funds tracked by Wall St. Rank hold VNDA as of Q2 2014.

  • THB Asset Management reported no remaining Vanda Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • THB Asset Management sold 207,900 Vanda Pharmaceuticals shares in Q2 2014, an estimated $3.38M.
  • THB Asset Management first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • THB Asset Management's Vanda Pharmaceuticals position peaked at $3.38M in Q1 2014.
  • 110 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2014.

Based on THB Asset Management's 13F filing for Q2 2014, filed 9 Jul 2014.